These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22182399)

  • 1. Measuring melasma patients' quality of life using willingness to pay and time trade-off methods in Thai population.
    Leeyaphan C; Wanitphakdeedecha R; Manuskiatti W; Kulthanan K
    BMC Dermatol; 2011 Dec; 11():16. PubMed ID: 22182399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing willingness-to-pay and time-trade-off as the measures of burden of psoriasis: A pooled analysis of community, hospital, and web-based samples in China.
    Shen M; Xiao H; Zhu W; Lu Y; Jing D; Kuang Y; Li M; Guan X; Sheng P; Su J; Chen X; Xiao Y
    J Dermatol; 2022 Nov; 49(11):1131-1138. PubMed ID: 35906766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients?
    Schiffner R; Schiffner-Rohe J; Gerstenhauer M; Hofstädter F; Landthaler M; Stolz W
    Br J Dermatol; 2003 Jun; 148(6):1153-60. PubMed ID: 12828743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to Pay and Time Trade-off in Thai Patients with Port-Wine Stains.
    Jantarakolica T; Wanitphakdeedecha R; Yan C; Yogya Y; Sirisuthivoranunt S; Wongdama S; Phumariyapong P; Sudhipongpracha T
    Clinicoecon Outcomes Res; 2022; 14():635-642. PubMed ID: 36171909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay and quality of life in patients with pruritic skin disorders.
    Stefanidou M; Evangelou G; Kontodimopoulos N; Koumaki D; Krueger-Krasagakis SE; Yosipovitch G; Krasagakis K
    Arch Dermatol Res; 2019 Apr; 311(3):221-230. PubMed ID: 30788568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
    Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
    Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of skin disorders associated with facial discoloration on quality of life: Novel insights explaining discordance between life quality scores and willingness to pay.
    Yang TT; Lan CE
    J Cosmet Dermatol; 2022 Jul; 21(7):3053-3058. PubMed ID: 34706154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial burden of lichen planus pigmentosus is similar to vitiligo, but greater than melasma: A cross-sectional study from a tertiary-care center in north India.
    Gupta V; Yadav D; Satapathy S; Upadhyay A; Mahajan S; Ramam M; Sharma VK
    Indian J Dermatol Venereol Leprol; 2021; 87(3):341-347. PubMed ID: 33943064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation.
    Smith RD
    Health Econ; 2001 Sep; 10(6):487-97. PubMed ID: 11550290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a health-related quality of life instrument for women with melasma.
    Balkrishnan R; McMichael AJ; Camacho FT; Saltzberg F; Housman TS; Grummer S; Feldman SR; Chren MM
    Br J Dermatol; 2003 Sep; 149(3):572-7. PubMed ID: 14510991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo.
    Amatya B; Pokhrel DB
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):114-118. PubMed ID: 32632057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay and quality of life in patients with rosacea.
    Beikert FC; Langenbruch AK; Radtke MA; Augustin M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):734-8. PubMed ID: 22583164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of different types of facial melanoses referring to the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital in 2019, and assessment of their effect on health-related quality of life.
    Amatya B; Jha AK; Shrestha S
    BMC Dermatol; 2020 Aug; 20(1):4. PubMed ID: 32746823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
    Thavorncharoensap M; Teerawattananon Y; Natanant S; Kulpeng W; Yothasamut J; Werayingyong P
    Clinicoecon Outcomes Res; 2013; 5():29-36. PubMed ID: 23345984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness-to-pay and Time Trade-off: The Burden of Disease in Patients with Benign Hyperpigmentation.
    Maymone MBC; Rajanala S; Widjajahakim R; Secemsky E; Saade D; Vashi NA
    J Clin Aesthet Dermatol; 2019 May; 12(5):46-48. PubMed ID: 31320977
    [No Abstract]   [Full Text] [Related]  

  • 18. Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.
    Kontodimopoulos N; Niakas D
    BMC Health Serv Res; 2006 Jan; 6():3. PubMed ID: 16412242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melasma and assessment of the quality of life in Brazilian women.
    Ikino JK; Nunes DH; Silva VP; Fröde TS; Sens MM
    An Bras Dermatol; 2015; 90(2):196-200. PubMed ID: 25830989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.